These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15000928)

  • 1. Clinical inquiries. Are ARBs or ACE inhibitors preferred for nephropathy in diabetes?
    Foreman BH; Chambliss ML
    J Fam Pract; 2004 Mar; 53(3):241-2. PubMed ID: 15000928
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes.
    Eberhard R; Dikow R
    Ann Med; 2002; 34(7-8):507-13. PubMed ID: 12553490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug companies should not have the final say in the design of clinical trials.
    Kurtzman NA
    Am J Kidney Dis; 2001 Nov; 38(5):1113-4. PubMed ID: 11684568
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-insulin-dependent diabetes mellitus, nephropathy, and the renin system.
    Hollenberg NK
    J Hypertens Suppl; 1997 Dec; 15(7):S7-13. PubMed ID: 9532515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy.
    Shlipak M
    Clin Evid; 2004 Dec; (12):814-33. PubMed ID: 15865682
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin II receptor blockers and nephropathy trials.
    Bloomgarden ZT
    Diabetes Care; 2001 Oct; 24(10):1834-8. PubMed ID: 11574450
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Ceriello A; Motz E
    N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11873779
    [No Abstract]   [Full Text] [Related]  

  • 9. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
    Greenwood V
    J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Walser M
    N Engl J Med; 2002 Feb; 346(9):705-7. PubMed ID: 11873778
    [No Abstract]   [Full Text] [Related]  

  • 11. Class benefits of AT(1) antagonists in Type 2 diabetes with nephropathy.
    Doggrell SA
    Expert Opin Pharmacother; 2002 May; 3(5):625-8. PubMed ID: 11996640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
    Suzuki H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():323-8. PubMed ID: 12430248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Large scale clinical trials in prevention of end-stage renal disease due to type 2 diabetes with angiotensin receptor antagonists].
    Suzuki H
    Nihon Rinsho; 2002 Oct; 60(10):2040-4. PubMed ID: 12397704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The RENAAL Study. Effect of losartan on diabetic nephropathy].
    Kuhlmann MK; Köhler H
    Internist (Berl); 2002 May; 43(5):675-7. PubMed ID: 12085539
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor blockers in diabetic nephropathy.
    Price DA; Hollenberg NK
    Curr Diab Rep; 2001 Dec; 1(3):267-74. PubMed ID: 12643209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan versus captopril in elderly patients with heart failure.
    Ball SG
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
    [No Abstract]   [Full Text] [Related]  

  • 19. Losartan versus captopril in elderly patients with heart failure.
    Jensen BV; Nielsen SL
    Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.